TOP STORIES — Diabetes News and Research
Pregnant Women Managing Diabetes with Dexcom G6 CGM System
How Air Pollution Plays a Role in Diabetes
Using Glucagon-like Peptide 1 Receptor Agonists In Type 1 Diabetes
MOST POPULAR ARTICLES OF THE MONTH
#1 Is Weight Loss or Physical Activity More Important for Preventing Type 2 Diabetes?
#2 Morning or Afternoon Exercise: Which Time of Day Provides the Most Benefits?
Letter from the Editor
When a relative is diagnosed with diabetes, your first inclination is to throw everything at the disease and then see what works best. That especially is the case if they start insulin on day 1. It started with a long acting insulin, an SGLT-2, and a GLP-1. This worked well till meal time insulin was needed. Then when a C-peptide test was done and type 1 was diagnosed, the Endo said no more Trulicity or Farxiga, which didn’t make sense. The reason was given that those products were not indicated for type 1 patients.
It could be this is changing; our intern, George McDowell, from LECOM, has a new study on the use of GLP-1 agonists for type 1 patients.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief
TOP STORIES -- Diabetes News and Research
Continuous glucose monitoring systems can enable pregnant women to monitor blood glucose more effectively.
Can exposure to particulate matter in air pollution increase an individual’s risk for type 2 diabetes?
Examining the effects of GLP-1RAs exenatide and liraglutide on weight and insulin dosage for type 1 diabetes patients.
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
